CONMED Corp — Director's Dealing 2016

Mar 4, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2016-03-03

Reporting Person: Snyder Mark D (EVP Mfg. Ops & Business System)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-03-03	Common Stock	M	6000	$19.26	Acquired	20060	Direct
2016-03-03	Common Stock	F	3879	$39.99	Disposed	16181	Direct
2016-03-03	Common Stock	M	4000	$26.09	Acquired	20181	Direct
2016-03-03	Common Stock	F	2979	$39.99	Disposed	17202	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-03-03	Sars (Stock Appreciation Rights)	$19.26	M	6000	Disposed	2020-06-01	Common Stock (6000)	Direct
2016-03-03	Sars (Stock Appreciation Rights)	$26.09	M	4000	Disposed	2022-06-01	Common Stock (4000)	Direct

Footnotes

F1: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.